Your browser doesn't support javascript.
loading
Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma.
Viardot, Andreas; Hess, Georg; Bargou, Ralf C; Morley, Nicholas J; Gritti, Giuseppe; Goebeler, Maria-Elisabeth; Iskander, Karim; Cohan, David; Zhang, Alicia; Franklin, Janet; Coyle, Luke.
Afiliación
  • Viardot A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Hess G; Department of Hematology, Oncology and Pneumology, Johannes Gutenberg-University, Mainz, Germany.
  • Bargou RC; Department of Internal Medicine II, ECTU, University Hospital Würzburg, Würzburg, Germany.
  • Morley NJ; Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, South Yorkshire, UK.
  • Gritti G; Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Goebeler ME; Department of Internal Medicine II, ECTU, University Hospital Würzburg, Würzburg, Germany.
  • Iskander K; Amgen Inc., Thousand Oaks, CA, USA.
  • Cohan D; Amgen Inc., Thousand Oaks, CA, USA.
  • Zhang A; Amgen Inc., Thousand Oaks, CA, USA.
  • Franklin J; Amgen Inc., Thousand Oaks, CA, USA.
  • Coyle L; Royal Northshore Hospital and Pathology North, St. Leonards, Australia.
Leuk Lymphoma ; 61(11): 2767-2770, 2020 11.
Article en En | MEDLINE | ID: mdl-32633177

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Linfoma de Células B Grandes Difuso / Anticuerpos Biespecíficos Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Linfoma de Células B Grandes Difuso / Anticuerpos Biespecíficos Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Alemania